GPCR's -Targeted Drug Discovery Summit

Media Partner



Meet Dr. GPCR Media Partner

   

  



Welcome to the GPCRs - Targeted Drug Discovery Summit 2022!

Unlocking the Next Wave of Clinically Relevant GPCR Targets

 

Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders to delve deep into the challenges associated with leveraging new structural data, explore emerging technologies and accelerate hit-to-lead optimization to successfully drug the next generation of GPCR targets with validated therapeutic relevance.


With 25+ pioneering speakers from large pharma, innovative biotech, and KOLs of academia who are shaping the landscape of GPCR drug discovery for the scientific community worldwide, join us in Boston to hear how they address the major challenges facing the industry:

 
  • Optimize Screening & Modeling Tools to Enhance GPCR Pharmacology & Drug Design

With effective screening & modeling for successful identification of GPCR targets remaining a key challenge in the field, immerse yourself in the advanced screening platforms & technologies to streamline your GPCR drug discovery efforts, with insights from Abalone BioMebias Discovery & Octant

 
  • Explore the Latest Advancements in GPCR Structure-Based Drug Design to Improve Ligand-Receptor Affinity

Delve into pioneering ways to capture GPCR complexes with higher resolution to solve structures of GPCRs for which limited tool ligands are available with insights from Sosei HeptaresOMass TherapeuticsMedical College of Wisconsin & University of Toronto

 
  • Discover the Expansion of GPCR-Targeting Modalities Beyond Traditional Small Molecules

As the industry continues to advance in GPCR therapeutics, it is becoming more important than ever to drug high value candidates with increased target specificity & efficacy. Hear expert insights into the hottest modalities from Tectonic TherapeuticDomain Therapeutics & Confo Therapeutics

 
  • Tune into How Companies are Leveraging Human Genetics for Hit-to-Lead Optimization of More Effective GPCR Targeted Drugs

With the recent success of discovery platforms based on human genetic data for better hit-to-lead optimization, hear from companies like Orion Biotechnology & Pathios Therapeutics on the emerging strategies to inform & expedite the drug discovery process towards clinical success

 
  • Discover Methods to Delineate GPCR Signaling Pathway Cross-talk for Novel Druggable Paradigms

Developing treatments for complex diseases requires understanding the complexity of receptor & signaling pathways. Hear first-hand from Eli Lilly & heptOME at our deep dive focus day on how to unravel the complexities of GPCR signaling mechanisms, bias signaling & allosteric modulation with therapeutic relevance



This is an in-person event between March 22 and 24, 2022 at the DoubleTree Suites Boston-Cambridge located at 400 Soldiers Field Rd, Boston, MA 02134, United States.

For more information and tickets please visit the Summit  page and use the discount code DRGPCR10 to obtain a 10% off the registration fees


 



Meet Dr. GPCR Media Partner

   

  

Do you need help with your GPCR project?


Contact us